Obstetrics and Gynecology

Episodes 1-16 of 30

- Anita L. Nelson, MD
  Peer
- Barbara Dehn
  Peer
12
CME/CE Live Broadcast
CME/CE Live Broadcast
Women's Health 2022: Beyond the Annual Visit - Midwest - October 7, 2022
Women's Health 2022: Beyond the Annual Visit - Midwest - October 7, 2022
Women's Health 2022: Beyond the Annual …
October 07, 2022
08:00 AM - 02:00 PM CDT
Learn more
- Anita L. Nelson, MD
  Peer
- Barbara Dehn
  Peer
10
CME/CE Live Broadcast
CME/CE Live Broadcast
Women's Health 2022: Beyond the Annual Visit - East - October 28, 2022
Women's Health 2022: Beyond the Annual Visit - East - October 28, 2022
Women's Health 2022: Beyond the Annual …
October 28, 2022
08:00 AM - 02:00 PM EDT
Learn more
- Anita L. Nelson, MD
  Peer
- Barbara Dehn
  Peer
3
CME/CE Live Broadcast
CME/CE Live Broadcast
Women's Health 2022: Beyond the Annual Visit - Mountain - November 4, 2022
Women's Health 2022: Beyond the Annual Visit - Mountain - November 4, 2022
Women's Health 2022: Beyond the Annual …
November 04, 2022
08:00 AM - 02:00 PM MDT
Learn more
- Anita L. Nelson, MD
  Peer
- Barbara Dehn
  Peer
4
CME/CE Live Broadcast
CME/CE Live Broadcast
Women's Health 2022: Beyond the Annual Visit - West - December 9, 2022
Women's Health 2022: Beyond the Annual Visit - West - December 9, 2022
Women's Health 2022: Beyond the Annual …
December 09, 2022
08:00 AM - 02:00 PM PST
Learn more
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Nanette F. Santoro, MD
  Peer
4
CME/CE
Updates in Vasomotor Symptom Treatment
Updates in Vasomotor Symptom Treatment
0.25 credits
Updates in Vasomotor Symptom Treatment
0.25 credits
- Ayman Al-Hendy, MD
  Peer
2
CME/CE
New Horizons in the Medical Management of Endometriosis: The Role of GnRH Antagonists: A “Voice of Patient/Voice of Provider” Curriculum
New Horizons in the Medical Management of Endometriosis: The Role of GnRH Antagonists: A “Voice of Patient/Voice of Provider” Curriculum
0.25 credits
New Horizons in the Medical Management of Endometriosis: The Role of GnRH Anta…
0.25 credits
- Mitchell D. Creinin, MD
  Peer
4
CME/CE
Contraceptive Continuity of Care During the COVID-19 Pandemic—A “Voice of Patient” Curriculum
Contraceptive Continuity of Care During the COVID-19 Pandemic—A “Voice of Patient” Curriculum
0.25 credits
Contraceptive Continuity of Care During the COVID-19 Pandemic—A “Voice of Patie…
0.25 credits
- Jeffery D. Dunn, PharmD, MBA
  Peer
- Gary M. Owens, MD
  Peer
- Anita L. Nelson, MD
  Peer
10
CME/CE
Focus on the New Menopause Management Horizon: Improving Outcomes Through Managed Care
Focus on the New Menopause Management Horizon: Improving Outcomes Through Managed Care
0.25 credits
Focus on the New Menopause Management Horizon: Improving Outcomes Through Manag…
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Stephanie Martin, DO
  Peer
14
CME/CE
Iron Deficiency Anemia in Patients Presenting with Abnormal Uterine Bleeding: The Role of Oral Iron Supplementation
Iron Deficiency Anemia in Patients Presenting with Abnormal Uterine Bleeding: The Role of Oral Iron Supplementation
0.25 credits
Iron Deficiency Anemia in Patients Presenting with Abnormal Uterine Bleeding: T…
0.25 credits
- Patty Cason, RN, MS, FNP-BC
  Peer
- Joely Pritzker, RN, MS, FNP-C
  Peer
11
CME/CE
Strategies to Improve Patient Communication About the Vaginal pH Modulator
Strategies to Improve Patient Communication About the Vaginal pH Modulator
0.25 credits
Strategies to Improve Patient Communication About the Vaginal pH Modulator
0.25 credits
- David J. Portman, MD
  Peer
- Patty Cason, RN, MS, FNP-BC
  Peer
- David L. Eisenberg, MD, MPH, FACOG
  Peer
14
CME/CE
The Vaginal pH Modulator: A Revolutionary Approach to Contraception
The Vaginal pH Modulator: A Revolutionary Approach to Contraception
0.25 credits
The Vaginal pH Modulator: A Revolutionary Approach to Contraception
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Ayman Al-Hendy, MD
  Peer
8
CME/CE
Misconceptions, Benefits, and Disadvantages of the Newer Oral GnRH Antagonists in the Management of Uterine Fibroids and Endometriosis
Misconceptions, Benefits, and Disadvantages of the Newer Oral GnRH Antagonists in the Management of Uterine Fibroids and Endometriosis
0.25 credits
Misconceptions, Benefits, and Disadvantages of the Newer Oral GnRH Antagonists …
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Andrea S. Lukes, MD, MHSc, FACOG
  Peer
14
CME/CE
Medical Management of Uterine Fibroids and Endometriosis: The Emerging Value Proposition Surrounding the New Oral GnRH Antagonists
Medical Management of Uterine Fibroids and Endometriosis: The Emerging Value Proposition Surrounding the New Oral GnRH Antagonists
0.25 credits
Medical Management of Uterine Fibroids and Endometriosis: The Emerging Value Pr…
0.25 credits
- Peter Goadsby, MD, PhD, DSc
  Peer
- Kathleen B. Mullin, MD
  Peer
16
CME/CE Broadcast Replay
CME/CE Broadcast Replay
Addressing the Unique Needs of Women with Migraine
Addressing the Unique Needs of Women with Migraine
0.75 credits
Addressing the Unique Needs of Women with Migraine
0.75 credits
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Erica E. Marsh MD, MSCI, FACOG
  Peer
19
CME/CE
Factors That Delay Diagnosis of Uterine Fibroids and Endometriosis: The Demographic Divide
Factors That Delay Diagnosis of Uterine Fibroids and Endometriosis: The Demographic Divide
0.25 credits
Factors That Delay Diagnosis of Uterine Fibroids and Endometriosis: The Demogra…
0.25 credits
- Anita L. Nelson, MD
  Peer
14
CME/CE Broadcast Replay
CME/CE Broadcast Replay
Optimizing Medical Management of Uterine Fibroids: Achieving Patient-Centered Goals and Outcomes
Optimizing Medical Management of Uterine Fibroids: Achieving Patient-Centered Goals and Outcomes
0.75 credits
Optimizing Medical Management of Uterine Fibroids: Achieving Patient-Centered G…
0.75 credits